Try our Advanced Search for more refined results

In Re: Zofran (Ondansetron)Products Liability Litigation

Track this case

Case overview

Case Number:

1:15-md-02657

Court:

Massachusetts

Nature of Suit:

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Multi Party Litigation:

Multi-district Litigation

Judge:

F. Dennis Saylor, IV

Firms

Companies

Sectors & Industries:

  1. March 18, 2020

    First Zofran Bellwether Delayed Indefinitely Due To COVID-19

    The first bellwether in multidistrict litigation over whether GlaxoSmithKline's anti-nausea medication Zofran causes birth defects has been postponed indefinitely amid the coronavirus pandemic, and a federal judge said Wednesday there is no timetable for when the long-running case may finally go to trial.

  2. February 20, 2020

    No Sanctions For GSK, But Both Sides Told To 'Dial It Back'

    GlaxoSmithKline will not face sanctions for a call to the U.S. Food and Drug Administration tied to multidistrict litigation over whether its anti-nausea medication Zofran causes birth defects, a Boston federal judge ruled Thursday, but he admonished lawyers on both sides to "dial ... back" their rhetoric.

  3. February 19, 2020

    Glaxo Says FDA Call About Zofran Suits Not 'Covert Lobbying'

    GlaxoSmithKline attorneys have told a Massachusetts federal judge that a 30-minute phone call with the U.S. Food and Drug Administration about multidistrict litigation alleging its anti-nausea medication Zofran causes birth defects wasn't "covert lobbying" and doesn't warrant sanctions.

  4. February 05, 2020

    Zofran Plaintiffs Say GSK Hid FDA Lobbying From Discovery

    Citing what GlaxoSmithKline attorneys have called "some crazy conspiracy theory," plaintiffs claimed Wednesday that GSK hid from discovery its efforts to lobby the U.S. Food and Drug Administration about the multidistrict litigation case alleging the company's anti-nausea medication Zofran caused birth defects.

  5. January 15, 2020

    GSK Seeks To Forgo Trial In First Zofran MDL Bellwether

    GlaxoSmithKline argued in court Wednesday to prevail on simply a paper record in the first trial in a multidistrict case over whether the company's anti-nausea medication Zofran caused birth defects, claiming a California mother cannot show she wouldn't have taken Zofran anyway, even with a birth defect warning.

  6. October 24, 2019

    GSK Loses Bid To End 53 Zofran Birth Defects Cases

    GlaxoSmithKline has largely lost its bid to end 58 cases in a consolidated suit claiming its anti-nausea medication Zofran caused birth defects when taken by pregnant women, as a Massachusetts federal judge said enough conflicting evidence remains to keep 53 of the suits alive.

  7. October 23, 2019

    Birth Defect Report Trimmed By Judge In Zofran MDL

    GlaxoSmithKline convinced a Massachusetts federal judge to slice off part of an expert report by a doctor who testified anti-nausea drug Zofran can cause birth defects when taken by pregnant women.

  8. July 19, 2019

    GSK Calls For Preemption Ruling In Zofran Birth Defect MDL

    GlaxoSmithKline has renewed its bid to end multidistrict litigation in Massachusetts federal court over claims it didn't warn customers about alleged birth defects resulting from its anti-nausea medication, saying a recent Supreme Court ruling opens the way for the judge to rule the claims are preempted by federal law.

  9. July 10, 2019

    GSK Gets 2nd Chance To Argue Preemption In Zofran MDL

    A Massachusetts federal judge on Wednesday said GlaxoSmithKline will get another chance to argue that claims its anti-nausea drug Zofran caused birth defects are federally preempted, adding he will seek guidance from the FDA after a landmark high court ruling put the preemption question in his hands.

  10. June 11, 2019

    GSK Seeks Ax Of Zofran Birth Defect Claims

    GlaxoSmithKline on Tuesday asked a Massachusetts federal judge to toss certain claims in multidistrict litigation alleging that its anti-nausea drug Zofran caused birth defects, saying that the patients hadn't shown the drug caused some of the purported defects.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!